Proteome Sciences
Proteome Sciences is a leading CRO specializing in proteomic services, offering advanced mass spectrometry-based protein discovery, detection, and biomarker development. With over 25 years of experience, they manufacture proprietary isobaric tags like TMT and TMTpro, and serve a global client base including top biopharma organizations. Their services include discovery proteomics, PTM analysis, targeted proteomics, and specialty proteomics, supporting drug development, biomarker validation, and translational research. They operate under ISO 9001:2015 and GCLP standards, providing comprehensive analytical services from sample QC to bioinformatics and reporting.
Industries
Nr. of Employees
small (1-50)
Proteome Sciences
Proteome Sciences plc, 1-2 The Courtyard, 55-57 High Street, Egham, Surrey, TW20 9EW, United Kingdom
Patents
Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties
US-11453621-B2
View Details
Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties
US-11453621-B2
View DetailsProducts
TMT and TMTpro Reagents
Isobaric tags used for protein quantification in mass spectrometry, available in 11-plex, 16-plex, and 18-plex formats.
CRO Proteomic Services
Contract research services offering mass spectrometry-based protein discovery and detection tools, including sample preparation, proteome characterization, and bioinformatics data interpretation.
Multiplexing of Tryptophan and its Metabolites
Analytical methods for simultaneous quantification of tryptophan and its metabolites, useful in disease research and clinical trials.
Bioinformatics Package
Dedicated tools for TMT/TMTpro and label-free data analysis, including data integration, feature selection, and biological process mapping.
Fluid Biomarker Unbiased Discovery
Services for protein biomarker discovery in biological fluids using TMT-based mass spectrometry.
Disease Profiling and Target Discovery
Proteomics services for identifying disease-related proteins and potential therapeutic targets, including post-translational modification analysis.
TMT and TMTpro Reagents
Isobaric tags used for protein quantification in mass spectrometry, available in 11-plex, 16-plex, and 18-plex formats.
CRO Proteomic Services
Contract research services offering mass spectrometry-based protein discovery and detection tools, including sample preparation, proteome characterization, and bioinformatics data interpretation.
Multiplexing of Tryptophan and its Metabolites
Analytical methods for simultaneous quantification of tryptophan and its metabolites, useful in disease research and clinical trials.
Bioinformatics Package
Dedicated tools for TMT/TMTpro and label-free data analysis, including data integration, feature selection, and biological process mapping.
Fluid Biomarker Unbiased Discovery
Services for protein biomarker discovery in biological fluids using TMT-based mass spectrometry.
Disease Profiling and Target Discovery
Proteomics services for identifying disease-related proteins and potential therapeutic targets, including post-translational modification analysis.
Services
Proteome Sciences offers discovery-based proteomics services to identify and quantify proteins in complex biological samples, supporting biomarker discovery and understanding disease mechanisms.
Specialized analysis of protein modifications such as phosphorylation, glycosylation, and others, to understand functional regulation and disease pathways.
Targeted mass spectrometry services including SRM and PRM for validation and quantification of specific protein biomarkers in large cohorts.
Bespoke services for chemical modifications, biosimilar comparisons, HCP analysis, and other specialized proteomic applications.
Proteome Sciences offers discovery-based proteomics services to identify and quantify proteins in complex biological samples, supporting biomarker discovery and understanding disease mechanisms.
Specialized analysis of protein modifications such as phosphorylation, glycosylation, and others, to understand functional regulation and disease pathways.
Targeted mass spectrometry services including SRM and PRM for validation and quantification of specific protein biomarkers in large cohorts.
Bespoke services for chemical modifications, biosimilar comparisons, HCP analysis, and other specialized proteomic applications.
News & Updates
The company announced its audited financial results for 2024 on April 10, 2025.
Proteome Sciences announced that its results for the year ending 31 December 2024 will be released on April 10, 2025, with a live presentation on April 11, 2025.
The company secured a contract from a US biopharmaceutical company for ongoing clinical trial sample analysis.
Proteome Sciences entered into new loan agreements totaling £1 million and announced board changes.
The company announced its audited financial results for 2024 on April 10, 2025.
Proteome Sciences announced that its results for the year ending 31 December 2024 will be released on April 10, 2025, with a live presentation on April 11, 2025.
The company secured a contract from a US biopharmaceutical company for ongoing clinical trial sample analysis.
Proteome Sciences entered into new loan agreements totaling £1 million and announced board changes.